GeneLink(OTC) GNLKQ

GeneLink, Inc. is a biotechnology company specializing in 12-gene DNA profiling services. The firm also offers customized nutritional supplements and a range of dermatological products. Established in 1994 and headquartered in Orlando, Florida, GeneLink aims to enhance individual health through genetic insights.

Products and Services

• 12-gene DNA profiling services for personalized health insights
• Bespoke nutritional supplements tailored to individual needs
• Comprehensive collection of dermatological products

Growth Outlook

• Expansion into personalized health markets is anticipated to drive revenue growth
• Increasing consumer interest in genetic testing supports demand for services
• Potential partnerships with healthcare providers could enhance market reach

Financial Highlights

• Recent quarterly revenue of 294,739 reflects a strategic focus on core offerings
• Trailing twelve months (TTM) gross profit margin stands at 21.75%
• Operating cash flow trends indicate a need for improved capital management

GeneLink, Inc. operates in a rapidly evolving biotechnology sector, where personalized health solutions are gaining traction. The company's focus on DNA profiling and tailored supplements positions it well to capitalize on growing consumer interest in health and wellness. Recent financial data indicates a revenue of 294,739 for the latest quarter, showcasing the potential for growth as the market for genetic testing expands. The gross profit margin of 21.75% suggests that the company is effectively managing its cost structure, although ongoing challenges in operating cash flow highlight the need for strategic financial management. Overall, GeneLink presents an intriguing opportunity for investors interested in the intersection of biotechnology and personalized health solutions.